Diabetes Drug May Offer 'Modest' Weight Loss for Very Obese Teens: Study

Byetta users showed small improvement, but drug is pricey and has side effects

HealthDay SHARE

He said his team plans to study other medications in the same class of drugs, and combinations of drugs, to see if they can produce better results. Recently, the Food and Drug Administration approved two new drugs for the treatment of obesity in adults, Belviq and Qsymia.

The study was funded by the University of Minnesota, the National Center for Research Resources and the National Institutes of Health. Kelly has received research funding from Amylin, which developed Byetta.

More information

To learn more about childhood obesity, visit the U.S. Centers for Disease Control and Prevention.

Copyright © 2012 HealthDay. All rights reserved.